Skip to search formSkip to main contentSkip to account menu

XP-828l

National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

Dermylex

Broader (1)

Milk Proteins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
XP-828 L in the Treatment of Mild-to-Moderate Psoriasis : A Randomized , Double-blind , Placebo-controlled Study
Advitech is the developer of XP-828L. Abstract Background: XP-828L, a protein extract obtained from sweet whey, has demonstrated… 
2007
2007
XP-828 L ( Dermylex ) , a new whey protein extract with potential benefit for mild to moderate psoriasis 1
Natural health products (NHPs) or complementary and alternative medicine (CAM) are commonly used to prevent disorders or support… 
2007
2007
XP-828L in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled study.
BACKGROUND XP-828L, a protein extract obtained from sweet whey, has demonstrated potential benefit for the treatment of mild to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)